Change In Fair Value Of Convertible Debentures Include Interest Expense

No definition available.

Name:	sclx_ChangeInFairValueOfConvertibleDebenturesIncludeInterestExpense
Namespace Prefix:	sclx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Derivative Warrant Liabilities

+ References

No definition available.

+ Details

Name:	sclx_DerivativeWarrantLiabilities
Namespace Prefix:	sclx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Fair value of contingent consideration.

+ References

No definition available.

+ Details

Name:	sclx_FairValueOfContingentConsideration
Namespace Prefix:	sclx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Purchased Revenue Liability

+ References

No definition available.

+ Details

Name:	sclx_PurchasedRevenueLiability
Namespace Prefix:	sclx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Secured Note Discount Rate

+ References

No definition available.

+ Details

Name:	sclx_SecuredNoteDiscountRate
Namespace Prefix:	sclx_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of contingent consideration recognized as part of consideration transferred in asset acquisition.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 25
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480060/805-50-25-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 30
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480027/805-50-30-1

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 30
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480027/805-50-30-2

+ Details

Name:	us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Exercise price per share or per unit of warrants or rights outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

+ Details

Name:	us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of warrants or rights outstanding.

+ References

No definition available.

+ Details

Name:	us-gaap_ClassOfWarrantOrRightOutstanding
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2E
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-10

+ Details

Name:	us-gaap_DebtInstrumentFairValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of principal of debt issued.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-03(i)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3

+ Details

Name:	us-gaap_DebtInstrumentIssuedPrincipal
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4A
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A

+ Details

Name:	us-gaap_DerivativeGainLossOnDerivativeNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Rate applied to the undiscounted amount of estimated damages for product liability to arrive at the present value recorded as of the balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 5.Y.Q1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480102/450-20-S99-1

+ Details

Name:	us-gaap_ProductLiabilityContingencyAccrualDiscountRate
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_SubsidiarySaleOfStockLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_AwardTypeAxis=sclx_WarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LongtermDebtTypeAxis=sclx_TrancheBNotesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LongtermDebtTypeAxis=sclx_GloperbaElyxybRoyaltyPurchaseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LongtermDebtTypeAxis=sclx_PurchasedRevenueLiabilityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=sclx_February2024BDOFirmWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=sclx_April2024RDOCommonWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=sclx_October2024NoteholderWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=sclx_December2024RDOCommonWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=sclx_DepositWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=sclx_RepresentativeWarrantsOutstandingMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=sclx_WarrantTransferAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Fair Value Measurements (Additional Information) (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended		3 Months Ended		6 Months Ended		12 Months Ended
	Oct. 31, 2024	Sep. 30, 2023	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024	Dec. 31, 2024	Feb. 29, 2024
Subsidiary, Sale of Stock [Line Items]
Note discount rate					128.46%		128.82%
Purchased revenue liability			$ 7,600		$ 7,600		$ 6,800
Warrants outstanding			5,467,692		5,467,692		156,220
(Gain) loss on derivative liability			$ (12,375)	$ (15,284)	$ (1,966)	$ (15,741)
Common stock upon conversation of cash					$ 3,000
Discount rate of FDA			9.40%		9.40%
Development Milestone Payment					$ 200		$ 200
Derivative warrant liabilities					$ 20,300
Warrants exercised price			$ 36.4		$ 36.4
Warrants
Subsidiary, Sale of Stock [Line Items]
(Gain) loss on derivative liability			$ 12,400	15,300	$ 2,000	15,700
Warrants exercised price								$ 74.38
Oramed Note
Subsidiary, Sale of Stock [Line Items]
Estimated fair value			18,500		18,500		12,200
Principle amount of issued debt		$ 101,900
Change in fair value of debt and liability instruments			3,500	$ 4,300	6,300	$ 8,100
Tranche BNotes Member
Subsidiary, Sale of Stock [Line Items]
Estimated fair value			21,400		21,400		23,600
Principle amount of issued debt	$ 50,000
Change in fair value of debt and liability instruments			4,200		6,700
Gloperba Elyxyb Royalty Purchase Agreement
Subsidiary, Sale of Stock [Line Items]
Purchased revenue liability			7,600		7,600		$ 6,800
Purchased Revenue Liability
Subsidiary, Sale of Stock [Line Items]
Change in fair value of debt and liability instruments			$ 700		$ 1,500
Private Placement
Subsidiary, Sale of Stock [Line Items]
Warrants outstanding			1,000,000		1,000,000
February 2024 BDO Firm Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants outstanding			3,803,447		3,803,447
April 2024 RDO Common Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants outstanding			15,000,000		15,000,000
October 2024 Note holder Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants outstanding			7,500,000		7,500,000
December 2024 RDO Common Warrants
Subsidiary, Sale of Stock [Line Items]
Warrants outstanding			57,512,958		57,512,958
Deposit Warrants
Subsidiary, Sale of Stock [Line Items]
Warrants outstanding			3,250,000		3,250,000
Representative Warrants Outstanding[Member]
Subsidiary, Sale of Stock [Line Items]
Warrants outstanding							470,588
Common Stock [Member] \| Private Placement
Subsidiary, Sale of Stock [Line Items]
Warrants outstanding			28,572		28,572
Common Stock [Member] \| February 2024 BDO Firm Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants outstanding			108,686		108,686
Common Stock [Member] \| April 2024 RDO Common Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants outstanding			428,572		428,572
Common Stock [Member] \| October 2024 Note holder Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants outstanding			214,284		214,284
Common Stock [Member] \| December 2024 RDO Common Warrants
Subsidiary, Sale of Stock [Line Items]
Warrants outstanding			1,642,871		1,642,871
Common Stock [Member] \| Deposit Warrants
Subsidiary, Sale of Stock [Line Items]
Warrants outstanding			3,250,000		3,250,000
Warrant Transfer Agreement [Member] \| Warrants
Subsidiary, Sale of Stock [Line Items]
Warrants outstanding			1,000,000		1,000,000		28,572
Warrants exercised price			$ 0.01		$ 0.01